eureKARE

eureKARE operates as an investment company dedicated to fostering innovation within the synthetic biology and microbiome sectors across Europe, the UK, and Israel. The firm specializes in identifying and nurturing early-stage scientific breakthroughs, providing crucial resources, funding, and strategic guidance to translate nascent ideas into viable enterprises. It actively builds and finances new biotech startups, bridging academic research with commercial development to create disruptive solutions for various challenges.

The company was co-founded by investor Alan Howard, with Rodolphe Besserve serving as its CEO, driven by an insight to cultivate European leadership in synthetic biology. Their initial vision centered on establishing an investment platform to empower scientists and capture the significant innovation emerging from European research institutions. This foundation enables eureKARE to actively participate in the creation and development of new companies rather than merely providing passive capital.

eureKARE's primary focus is on supporting promising synthetic biology and microbiome startups, acting as a strategic partner to scientists and entrepreneurs. The firm’s long-term vision is to establish a robust synthetic biology network throughout Europe, fostering groundbreaking research and developing a new generation of companies. It aims to accelerate the adoption of these advanced biological technologies to address pressing environmental and sustainability issues, thereby shaping the future of biotechnology.